Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / ISHARES BIOTECH
-
Total 13F shares
-
31,072,085
-
Share change
-
+384,705
-
Total reported value
-
$3,936,382,892
-
Put/Call ratio
-
78%
-
Price per share
-
$126.51
-
Number of holders
-
788
-
Value change
-
+$47,323,371
-
Number of buys
-
179
-
Number of sells
-
432
Institutional Holders of ISHARES TR - ISHARES BIOTECH (IBB) as of Q2 2025
As of 30 Jun 2025,
ISHARES TR - ISHARES BIOTECH (IBB) was held by
788 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
31,072,085 shares.
The largest 10 holders included
BANK OF AMERICA CORP /DE/, CITIGROUP INC, MORGAN STANLEY, GOLDMAN SACHS GROUP INC, UBS Group AG, JPMORGAN CHASE & CO, WELLS FARGO & COMPANY/MN, Royal Bank of Canada, HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND, and COMMERCE BANK.
This page lists
789
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.